Paper33765954
Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.
Liu L and 6 others. BMC Cancer, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor. Papers, record 33765954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33765954
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Gene Regulatory Networks | Major topic |
| Kidney Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Wilms Tumor | Major topic |
| Child | |
| Computational Biology | |
| Datasets as Topic | |
| Gene Expression Profiling | |
| Gene Expression Regulation, Neoplastic | |
| Genetic Predisposition to Disease | |
| Genetic Testing | |
| Humans | |
| Neoplasm Staging | |
| Prognosis | |
| Risk Assessment |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29912901 | Germline mutations and somatic inactivation of TRIM28 in Wilms tumour. | PLoS Genet | 2018 | https://conductscience.org/library/papers/29912901 | PubMed |
| 2 | 30898709 | High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. | Gene | 2019 | https://conductscience.org/library/papers/30898709 | PubMed |
| 3 | 12925520 | Exploration, normalization, and summaries of high density oligonucleotide array probe level data. | Biostatistics | 2003 | https://conductscience.org/library/papers/12925520 | PubMed |
| 4 | 29693365 | Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical Analysis | Asian Pac J Cancer Prev | 2018 | https://conductscience.org/library/papers/29693365 | PubMed |
| 5 | 29497314 | MiR-1180-5p regulates apoptosis of Wilms' tumor by targeting p73. | Onco Targets Ther | 2018 | https://conductscience.org/library/papers/29497314 | PubMed |
| 6 | 31020869 | Emerging strategies to target the dysfunctional cohesin complex in cancer. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/31020869 | PubMed |
| 7 | 30008927 | Kadsurenone is a useful and promising treatment strategy for breast cancer bone metastases by blocking the PAF/PTAFR signaling pathway. | Oncol Lett | 2018 | https://conductscience.org/library/papers/30008927 | PubMed |
| 8 | 19174555 | Biological characterization of AT7519, a small-molecule inhibitor of cyclin-dependent kinases, in human tumor cell lines. | Mol Cancer Ther | 2009 | https://conductscience.org/library/papers/19174555 | PubMed |
| 9 | 19114008 | WGCNA: an R package for weighted correlation network analysis. | BMC Bioinformatics | 2008 | https://conductscience.org/library/papers/19114008 | PubMed |
| 10 | 30988639 | ITLNI identified by comprehensive bioinformatic analysis as a hub candidate biological target in human epithelial ovarian cancer. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/30988639 | PubMed |
| 11 | 20309759 | Weighted gene coexpression network analysis: state of the art. | J Biopharm Stat | 2010 | https://conductscience.org/library/papers/20309759 | PubMed |
| 12 | 31010254 | Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31010254 | PubMed |
| 13 | 31010829 | Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31010829 | PubMed |
| 14 | 29904957 | Identification of gene expression profiles and key genes in subchondral bone of osteoarthritis using weighted gene coexpression network analysis. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/29904957 | PubMed |
| 15 | 23174227 | Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology. | J Urol | 2013 | https://conductscience.org/library/papers/23174227 | PubMed |
| 16 | 30979499 | Inhibition of cyclin-dependent kinases by AT7519 is effective to overcome chemoresistance in colon and cervical cancer. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30979499 | PubMed |
| 17 | 17539021 | Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group. | Pediatr Blood Cancer | 2008 | https://conductscience.org/library/papers/17539021 | PubMed |
| 18 | 21283776 | Is my network module preserved and reproducible? | PLoS Comput Biol | 2011 | https://conductscience.org/library/papers/21283776 | PubMed |
| 19 | 30968289 | Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives. | Drugs | 2019 | https://conductscience.org/library/papers/30968289 | PubMed |
| 20 | 21455458 | Understanding survival analysis: Kaplan-Meier estimate. | Int J Ayurveda Res | 2010 | https://conductscience.org/library/papers/21455458 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41827743 | Tumor-Associated Macrophage Polarization in Wilms' Tumor After Neoadjuvant Chemotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41827743 | PubMed |
| 41371711 | ALKBH5 gene polymorphisms and Wilms tumour susceptibility in children from East China: a case-control study. | BMJ Paediatr Open | 2025 | https://conductscience.org/library/papers/41371711 | PubMed |
| 40098972 | Integration of single-nuclei and spatial transcriptomics to decipher tumor phenotype predictive of relapse-free survival in Wilms tumor. | Front Immunol | 2025 | https://conductscience.org/library/papers/40098972 | PubMed |
| 38426157 | Prognostic role of primary tumor size in Wilms tumor. | Oncol Lett | 2024 | https://conductscience.org/library/papers/38426157 | PubMed |
| 38142265 | Cancer predisposition signaling in Beckwith-Wiedemann Syndrome drives Wilms tumor development. | Br J Cancer | 2024 | https://conductscience.org/library/papers/38142265 | PubMed |
| 37283791 | WDR4 gene polymorphisms and Wilms tumor susceptibility in Chinese children: A five-center case-control study. | J Cancer | 2023 | https://conductscience.org/library/papers/37283791 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33765954
GET https://conductscience.org/api/papers/v1/33765954/references?page=2